What makes tesamorelin the reference point for GHRH-axis research
People looking up tesamorelin peptide often want to know why it appears in GHRH research and how its structure changes its behavior. In other words, the key questions are what changed, what evidence supports the explanation, and how comparisons should be recorded. This guide separates cell and animal findings from human evidence. It is for research use only and does not address use in people or animals.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), built on the full endogenous GHRH sequence with a trans-2-hexenoic acid group conjugated to its N-terminus. That addition is a structural reason researchers distinguish the molecule from native GHRH.
Why does the N-terminal modification matter?
Native GHRH is readily cleaved by dipeptidyl peptidase IV after its second residue, at the bond between residues two and three. Tesamorelin's trans-2-hexenoic acid group shields that end of the molecule. That modification can increase resistance to this enzymatic cleavage; it does not establish a universal shelf life in every aqueous buffer.
This stability difference affects incubation planning and interpretation of receptor-binding or cAMP-response data. The change preserves activity but does not reproduce the natural ligand's exact profile. Researchers should use values reported for tesamorelin rather than borrowing them from native GHRH.
The N-terminal tyrosine found in active GHRH fragments remains in tesamorelin's sequence. Cell studies support receptor engagement, but that finding alone does not establish an outcome in an animal model or in humans.
What the evidence says—and what remains uncertain
Three analogues in the PureDose Labs catalog occupy adjacent positions on the GHRH axis, and mixing them up on a bench label is easier than it sounds when vials are unlabeled after reconstitution.
Sermorelin is the shorter GHRH fragment commonly used for fragment-versus-full-length comparisons. CJC-1295 No DAC uses a different chemical strategy from tesamorelin. The CJC No DAC / Ipamorelin blend pairs a GHRH analogue with a ghrelin mimetic, while the Tesamorelin / Ipamorelin Blend (10 mg/3 mg) is separate. The exact analogue belongs in every study record.
- Cell work can describe receptor binding and signaling under controlled conditions.
- Animal studies add whole-organism context but do not automatically predict results in people.
- Human studies answer different questions, and their findings should not be stretched beyond the population and methods reported.
What the dry format changes
PureDose Labs stocks tesamorelin as a freeze-dried powder in a 10 mg vial. Removing water leaves a dry cake suited to storage and transit. Each lot is made to the stated purity target and checked by an independent laboratory using HPLC. The certificate states the method, measured value, and analysis date.
A companion Tesamorelin / Ipamorelin Blend is listed at 10 mg/3 mg per vial. It supports studies of GHRH-axis and ghrelin-axis signaling without combining two separately dissolved stocks.
Documentation for any lot is available on request before or after ordering. If a value was not measured for a given lot, the certificate renders it as a dash rather than an estimate.
Keeping the dissolved peptide intact
Dry peptide is less vulnerable than a dissolved preparation. Common sources of unreliable data include the wrong solvent, rough mixing, and missing records about solution age.
Solvent choice should come from the qualified protocol and material-specific documentation. Bacteriostatic water contains benzyl alcohol, while sterile water for injection has no antimicrobial preservative. That difference affects compatibility and contamination control, but it does not establish tesamorelin's chemical stability or justify a universal hold time.
Use the mixing method, temperature, and hold time defined by the qualified protocol. Record the solvent lot, measured volume, preparation time, storage condition, and any temperature excursion so another researcher can reconstruct the preparation.
Concentration arithmetic for laboratory preparations
The relationship is fixed: concentration (mg/mL) equals mass (mg) divided by volume (mL). A 10 mg vial reconstituted with 1 mL of solvent yields a stock concentration of 10 mg/mL. Reconstituted with 2 mL, the concentration is 5 mg/mL. Reconstituted with 4 mL, it is 2.5 mg/mL — retain the decimal and do not round in reference-standard work.
Working concentrations are prepared by diluting the stock with an appropriate aqueous buffer. Serial dilutions from a 10 mg/mL stock can reach the nanomolar range used in receptor-binding studies. The Reconstitution Calculator and Peptide Calculator perform the arithmetic and provide a printable record.
One thing the arithmetic does not tell you: it assumes the label mass is accurate. This is why the certificate matters. The measured purity value affects how much target peptide is present, so materials with different measured purity may not behave identically in a quantitative study.
Temperature limits and uncertain stability data
Use the storage condition printed for the lot and preserve any supporting stability document. A general statement about freeze-dried peptides cannot validate a specific temperature or transit window for tesamorelin.
Dissolved preparations may be more susceptible to degradation than dry material, but the acceptable temperature, light exposure, and freeze-thaw history remain method-specific. Write the preparation date and actual storage condition on each vial; do not rely on memory for solution age.
Published stability data for dissolved GHRH analogues under refrigeration varies between sources. Some figures in protocol libraries do not cite a peer-reviewed stability study. Treat an unsupported duration as a working habit rather than a validated value, and plan conservatively.
What analytical records can and cannot prove
Every tesamorelin lot stocked by PureDose Labs is accompanied by a certificate of analysis from third-party HPLC analysis. The certificate identifies the lot, states the analytical method, records the measured purity value, and notes the date of testing. Lot numbers on the vial and the certificate must match — a certificate from a different batch is not a valid record for the material in hand.
Researchers may request the current lot's file before ordering. Identity confirmation by mass spectrometry and purity by HPLC answer different questions. One checks which compound is present; the other estimates its share relative to detected impurities.
The Testing and Documentation page on the site describes what is measured, by whom, and in what format for all catalog entries.
How to buy tesamorelin peptide from PureDose Labs
Researchers looking to buy tesamorelin peptide for laboratory use can access both the standalone 10 mg vial and the Tesamorelin / Ipamorelin Blend (10 mg/3 mg) directly from their product listings. All products ship from the PureDose Labs facility in Miami, Florida. Orders placed before 2:00 PM EST dispatch the same business day via USPS Priority or UPS Ground, with tracking emailed once the label is generated. Domestic delivery typically takes 2 to 4 business days.
When selecting vial count, account for the number of independent experiments, the planned stock concentration, and any freeze-thaw aliquoting strategy. If an extended research program requires volume beyond standard retail quantities, contact the support team with the compound name and monthly quantity needed; pricing and lead times are quoted per compound and quantity. All supply is subject to research-use-only terms.
Lot documentation may be requested before purchase. If the lot on hand changes between an initial documentation review and a subsequent order, the new lot's file can be sent on request before dispatch.
Supply terms and research-use-only scope
Tesamorelin peptide supplied by PureDose Labs is for research use only. It is not for human or animal consumption and is not supplied for diagnostic, therapeutic, or any clinical application. Orders where a non-laboratory use is indicated are declined.
All materials are supplied within the specifications stated in their lot documentation. PureDose Labs does not make comparative quality claims about other suppliers' material and does not summarize or restate analytical data in its own words — the certificate of analysis is the record. If a value a researcher needs was not measured for a given lot, that is stated directly rather than estimated.
Questions about lot documentation, bulk supply, or catalog scope can be directed to the support team. Replies state what is on file and what happens next.
Frequently asked questions
What is tesamorelin peptide and why does it appear in GHRH-axis research panels?
Tesamorelin is a synthetic GHRH analogue built on the full endogenous GHRH sequence with a trans-2-hexenoic acid group at its N-terminus. That modification increases resistance to a known enzymatic cleavage pathway, but it does not establish a universal aqueous shelf life. Researchers study it under controlled laboratory conditions.
How does tesamorelin differ from sermorelin and CJC-1295 No DAC?
Sermorelin is a shorter GHRH fragment with a different reported persistence profile. CJC-1295 No DAC uses a different chemical modification. Tesamorelin uses the full GHRH sequence plus a trans-hexenoic acid group. These compounds are structurally distinct and should not be interchanged in study designs or lot records.
How do I calculate working concentration from a 10 mg tesamorelin vial?
Concentration equals mass divided by volume. A 10 mg vial reconstituted with 1 mL yields 10 mg/mL; with 2 mL it yields 5 mg/mL; with 4 mL it yields 2.5 mg/mL. Do not round — retain the decimal in reference-standard work. The Reconstitution Calculator on the PureDose Labs site handles multi-step dilution sequences and produces a printable record.
What solvent should be used to reconstitute tesamorelin?
Use the solvent specified by the qualified protocol and material-specific documentation. Bacteriostatic water contains benzyl alcohol; sterile water for injection does not contain an antimicrobial preservative. That distinction can affect compatibility and contamination control, but neither label establishes tesamorelin's chemical stability or a universal storage period.
Is a tesamorelin and ipamorelin blend available as a single preparation?
Yes. PureDose Labs stocks a Tesamorelin / Ipamorelin Blend at 10 mg/3 mg per vial. Tesamorelin represents the GHRH axis; ipamorelin is a ghrelin-mimetic pentapeptide. A single-vial format avoids combining two separately dissolved stocks, reducing dilution steps in studies that examine both axes.
How should reconstituted tesamorelin solution be handled to maintain assay integrity?
Follow the lot-specific storage condition and the qualified method rather than applying a universal temperature or hold time. Record the solvent, preparation date, actual storage condition, light exposure, and freeze-thaw history. If supporting solution-stability data are absent, report the hold time as uncertain instead of inventing one.
Can I review lot documentation before placing an order?
Yes. Contact PureDose Labs with the product name and the current lot's certificate of analysis will be sent before purchase. The document states the analytical method, the measured purity value, and the date of testing. Any specification not measured for that lot appears as a dash, not an estimate.
What are the shipping timelines for tesamorelin orders?
Orders placed before 2:00 PM EST dispatch the same business day from Miami, Florida via USPS Priority or UPS Ground. Tracking is emailed when the label is generated. Domestic delivery typically takes 2 to 4 business days. If tracking has not updated after two days, contact support to open a carrier trace.